Hormones for suspected impaired fetal growth (Cochrane Review)

A substantive amendment to this systematic review was last made on 11 November 2002. Cochrane reviews are regularly checked and updated if necessary.

Background: It has been suggested that oestrogens may improve fetal growth due to an increase in nutritional supply to the fetus from greater uterine blood flow.

Objectives: The objective of this review was to assess the effects of hormone administration for suspected impaired fetal growth and perinatal outcome.

Search strategy: We searched the Cochrane Pregnancy and Childbirth Group trials register (1 November 2002).

Selection criteria: Acceptably controlled trials of hormone administration for suspected impaired fetal growth which report fetal, perinatal or maternal outcomes.

Data collection and analysis: Eligibility and trial quality were assessed.

Main results: No studies were included since none of the potentially relevant trials reported clinical outcomes.

Reviewers' conclusions: There is not enough evidence to evaluate the clinical use of hormone administration for suspected impaired fetal growth.

Citation: Say L, Gülmezoglu AM, Hofmeyr GJ. Hormones for suspected impaired fetal growth (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.

---

This is an abstract of a regularly updated, systematic review prepared and maintained by the Cochrane Collaboration. The full text of the review is available in The Cochrane Library (ISSN 1464-780X).

The Cochrane Library is designed and produced by Update Software Ltd.

Update Software Ltd, Summertown Pavilion, Middle Way, Oxford OX2 7LG, UK
(Tel:+44 1865 513902; Fax:+44 1865 516918)

File Reference: AB000109.htm